Related content

Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies

By Ghiringhelli François  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 758-764

Springer Publishing Company

Access to resources Recommend Favorite

Antineoplastics: Chemotherapy and radiotherapy-induced myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cytarabine/doxycycline/methotrexate: Chemotherapy-induced nausea and vomiting, Wernicke's syndrome and Korsakoff syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1312, 2010-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

By Thompson Philip A.   O'Brien Susan M.   Wierda William G.   Ferrajoli Alessandra   Stingo Francesco   Smith Susan C.   Burger Jan A.   Estrov Zeev   Jain Nitin   Kantarjian Hagop M.   Keating Michael J.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3612-3621

Blackwell Publishing

Access to resources Recommend Favorite

Chemotherapy-induced peripheral neurotoxicity

By Cavaletti Guido   Marmiroli Paola  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 535-546

Informa Healthcare

Access to resources Recommend Favorite